SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001104659-20-092693
Filing Date
2020-08-10
Accepted
2020-08-10 15:53:02
Documents
6

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 15699
2 PART II AND III tm2018205d6_partiiandiii.htm PART II AND III 13334
3 EXHIBIT 11.1 tm2018205d6_ex11-1.htm EX1A-11 CONSENT 3381
4 EXHIBIT 12.1 tm2018205d6_ex12.htm EX1A-12 OPN CNSL 6689
5 GRAPHIC image_003.jpg GRAPHIC 3787
6 GRAPHIC image_004.jpg GRAPHIC 9038
  Complete submission text file 0001104659-20-092693.txt   58110
Mailing Address 515 MADISON AVENUE NEW YORK NY 10022
Business Address 515 MADISON AVENUE NEW YORK NY 10022 917-930-4332
Fisher Wallace Laboratories, Inc. (Filer) CIK: 0001787792 (see all company filings)

IRS No.: 208131183 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-11229 | Film No.: 201089172
SIC: 3841 Surgical & Medical Instruments & Apparatus